Nailesh Bhatt - May 17, 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, power of attorney
Stock symbol
SONN
Transactions as of
May 17, 2023
Transactions value $
$5,800
Form type
4
Date filed
5/18/2023, 08:00 AM
Previous filing
Dec 22, 2022
Next filing
Dec 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase $5.8K +25K +436.07% $0.23 30.7K May 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested RSUs.